Cargando…

Stick or twist: Everolimus for seizures in tuberous sclerosis complex during the COVID-19 pandemic

Detalles Bibliográficos
Autores principales:	Moloney, Patrick B., Delanty, Norman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	British Epilepsy Association. Published by Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255220/ https://www.ncbi.nlm.nih.gov/pubmed/34252878 http://dx.doi.org/10.1016/j.seizure.2021.06.035

Ejemplares similares

Everolimus dosing recommendations for tuberous sclerosis complex–associated refractory seizures
por: Franz, David N., et al.
Publicado: (2018)

Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives
por: Overwater, Iris E, et al.
Publicado: (2019)

Everolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disorders
por: Krueger, Darcy A., et al.
Publicado: (2017)

Giant Shagreen Patch in Tuberous Sclerosis Complex
por: Kuntoji, V., et al.
Publicado: (2018)

Intracerebral hemorrhage in a patient with tuberous sclerosis complex
por: Yang, Lei, et al.
Publicado: (2016)

Everolimus induced organizing pneumonia in a patient with tuberous sclerosis complex
por: Lanfranco, Julio, et al.
Publicado: (2021)

Effect of everolimus on multifocal micronodular pneumocyte hyperplasia in tuberous sclerosis complex
por: Daccord, Cécile, et al.
Publicado: (2020)

Space-Occupying Intraventricular Vascular Lesion in Tuberous Sclerosis Complex
por: Lv, Hongtao, et al.
Publicado: (2022)

Everolimus and intensive behavioral therapy in an adolescent with tuberous sclerosis complex and severe behavior()()()
por: Gipson, Tanjala T., et al.
Publicado: (2013)

Tuberous sclerosis with head injury
por: Mitra, Ranadhir, et al.
Publicado: (2013)

Atypical Presentation of Renal Angiomyolipomas in a Child with Tuberous Sclerosis Complex
por: Ferrara, Pietro, et al.
Publicado: (2011)

A comparison of two studies and the prevalence and sex ratio of Neurodevelopmental conditions in Tuberous Sclerosis Complex
por: Runicles, Abigail K., et al.
Publicado: (2021)

Tuberous Sclerosis with Multiple Unusual Associations
por: Choudhary, Aakanksha, et al.
Publicado: (2021)

The Effect of Everolimus on Subependymal Giant Cell Astrocytoma (SEGA) in Children with Tuberous Sclerosis Complex
por: BAKHTIARY, Hassan, et al.
Publicado: (2021)

Sequential everolimus for angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study
por: Gu, Liangyou, et al.
Publicado: (2021)

Resolution of multifocal micronodular pneumocyte hyperplasia with everolimus in a patient with tuberous sclerosis complex
por: Shoji, Tetsuaki, et al.
Publicado: (2021)

Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
por: Luo, Cong, et al.
Publicado: (2021)

TuberOus SClerosis registry to increAse disease awareness (TOSCA) Post-Authorisation Safety Study of Everolimus in Patients With Tuberous Sclerosis Complex
por: Kingswood, J. Chris, et al.
Publicado: (2021)

Endocrinopathy complicating a case of Tuberous sclerosis
por: Kota, Sunil Kumar, et al.
Publicado: (2013)

Yet another pulmonary manifestation of tuberous sclerosis
por: Bhawna, Satija, et al.
Publicado: (2014)

Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy
por: Capal, Jamie K, et al.
Publicado: (2016)

Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guide
por: Davies, Mark, et al.
Publicado: (2017)

Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia
por: Leitner, Dominique F., et al.
Publicado: (2022)

Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice
por: Cockerell, Ine, et al.
Publicado: (2023)

Fibrous Plaque of the Eyelid in a Patient with Tuberous Sclerosis Responding to Everolimus
por: Park, Sung-Min, et al.
Publicado: (2018)

Giant renal angiomyolipomas in a patient with tuberous sclerosis
por: de Miranda, Carla Lorena Vasques Mendes, et al.
Publicado: (2018)

Simultaneous occurrence of nonepileptic and epileptic seizures during a single period of in‐patient video‐electroencephalographic monitoring
por: El‐Naggar, Hany, et al.
Publicado: (2017)

Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis
por: Bissler, John J., et al.
Publicado: (2018)

Mutational analysis of renal angiomyolipoma associated with tuberous sclerosis complex and the outcome of short-term everolimus therapy
por: Ni, Jianxin, et al.
Publicado: (2019)

Seizure Localization in Patients with Multiple Tubers: Presurgical Evaluation in Tuberous Sclerosis
por: Song, Pamela, et al.
Publicado: (2012)

Clinical seizure semiology is subtle and identification of seizures by parents is unreliable in infants with tuberous sclerosis complex
por: Lynch, Matthew, et al.
Publicado: (2022)

Erratum: Fibrous Plaque of the Eyelid in a Patient with Tuberous Sclerosis Responding to Everolimus
por: Park, Sung-Min, et al.
Publicado: (2018)

Effect and Complications of Everolimus Use for Giant Cardiac Rhabdomyomas with Neonatal Tuberous Sclerosis
por: Shibata, Yuka, et al.
Publicado: (2019)

Metformin for the management of tuberous sclerosis: What does the evidence tell us?
por: Srinivasan, Anirudh, et al.
Publicado: (2021)

Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex
por: Franz, David Neal
Publicado: (2013)

Use of the mTOR inhibitor everolimus in a patient with multiple manifestations of tuberous sclerosis complex including epilepsy
por: Wheless, James W.
Publicado: (2015)

Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study
por: Franz, David N., et al.
Publicado: (2016)

EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex
por: Fogarasi, Andras, et al.
Publicado: (2016)

Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial
por: Robles, Nicolás Roberto, et al.
Publicado: (2016)

Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial
por: Cai, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cfn0afjfvh4mnmblvotujq1bho